Eli Lilly | LLY - Ebitda

Stock Price
997.00
Daily Change
-47.13 -4.51%
Monthly
-4.27%
Yearly
20.69%
Q1 Forecast
1,005.21

Eli Lilly reported $7.5B in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
AbbVie USD 4.34B 56M Jun/2025
Abbott USD 3.09B 44M Sep/2025
ALKERMES USD 121.55M 4.99M Sep/2025
Amgen USD 5.91B 2.31B Sep/2025
AstraZeneca USD 4.96B 127M Jun/2025
Baxter International USD 462M 137M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Drreddys Laboratories INR 21.59B 1.49B Dec/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Glaxosmithkline GBP 4.75B 1.52B Sep/2025
J&J USD 9.52B 389M Sep/2025
Medtronic USD 2.44B 139M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Neurocrine Biosciences USD 246.7M 93.8M Sep/2025
Novartis USD 5.88B 290M Sep/2025
Novartis USD 5.84B 235M Sep/2025
Novo Nordisk DKK 31.44B 6.84B Sep/2025
Perrigo USD 258.8M 37.3M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Prestige Brands USD 86.83M 7.19M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
Sanofi EUR 5.66B 3.77B Sep/2025
United Therapeutics USD 436.8M 34.2M Jun/2025
Zoetis USD 1.04B 87M Sep/2025